Eluxadoline API Market In Global
Eluxadoline is a medication taken by mouth for the treatment of diarrhea and abdominal pain in in ... Read More
Eluxadoline is a novel, orally-active drug approved for the treatment of diarrhea and abdominal pain in individuals with diarrhea-predominant irritable bowel syndrome (IBS-D).
This report contains market size and forecasts of Eluxadoline Reagent in global, including the following market information:
Global Eluxadoline Reagent Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Eluxadoline Reagent Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Eluxadoline Reagent companies in 2021 (%)
The global Eluxadoline Reagent market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Eluxadoline Reagent include LGC, SimSon Pharma, ChemScence, Adooq Bioscience, BioVision, LifeSpan BioSciences, Biosynth Carbosynth, AbMole and Key Organics and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Eluxadoline Reagent manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Eluxadoline Reagent Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Eluxadoline Reagent Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Eluxadoline Reagent Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Eluxadoline Reagent Market Segment Percentages, by Application, 2021 (%)
Research
Medical
Global Eluxadoline Reagent Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Eluxadoline Reagent Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Eluxadoline Reagent revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Eluxadoline Reagent revenues share in global market, 2021 (%)
Key companies Eluxadoline Reagent sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Eluxadoline Reagent sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
LGC
SimSon Pharma
ChemScence
Adooq Bioscience
BioVision
LifeSpan BioSciences
Biosynth Carbosynth
AbMole
Key Organics
Wuhan Sun-Shine Bio-Technology
Eluxadoline is a medication taken by mouth for the treatment of diarrhea and abdominal pain in in ... Read More
Eslicarbazepine acetate,an antiepileptic drug, is a dual a dual Inhibitor of β-Secretase and vol ... Read More
Eslicarbazepine acetate is an anticonvulsant medication approved for use in Europe and the United ... Read More
Iloperidone is an atypical antipsychotic and adrenergic, dopamine, and serotonin (5-HT) receptor ... Read More